Editas Medicine (8EM) Q2 2026 Earnings Report
DE:8EM Q2 2026 EPS Results
- Actual EPS
- -EUR 0.13
- Consensus EPS
- -EUR 0.24
- Beat/Miss
- Beat by +EUR 0.11
- One Year Ago EPS
- -EUR 0.56
DE:8EM Q2 2026 Revenue Results
- Actual Revenue
- EUR 10.61M
- Expected Revenue
- EUR 2.54M
- Beat/Miss
- Beat by +EUR 8.07M
- YoY Revenue Growth
- +232.31%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/05/2026
- Time
- After Close
- Conference Call
- Wednesday, August 5, 2026
DE:8EM Upcoming Earnings
Editas Medicine's next earnings date is estimated for November 9, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8EM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 09, 2026 | 2026 (Q3) | -0.17- | -0.25 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | -0.24-0.13 | -0.56 | 76.19% (+0.43) | |
| May 05, 2026 | 2026 (Q1) | -0.23-0.23 | -0.82 | 71.74% (+0.59) | |
| Mar 09, 2026 | 2025 (Q4) | -0.21-0.05 | -0.49 | 89.09% (+0.44) | |
| Nov 10, 2025 | 2025 (Q3) | -0.26-0.25 | -0.67 | 62.67% (+0.42) | |
| Aug 12, 2025 | 2025 (Q2) | -0.35-0.56 | -0.73 | 23.17% (+0.17) | |
| May 12, 2025 | 2025 (Q1) | -0.50-0.82 | -0.68 | -21.05% (-0.14) | |
| Mar 05, 2025 | 2024 (Q4) | -0.34-0.49 | -0.21 | -139.13% (-0.29) | |
| Nov 04, 2024 | 2024 (Q3) | -0.67-0.67 | -0.49 | -36.36% (-0.18) | |
| Aug 07, 2024 | 2024 (Q2) | -0.63-0.73 | -0.5 | -46.43% (-0.23) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed